What does Lantheus Holdings, Inc. do?

Jun 22 2025 06:49 PM IST
share
Share Via
Lantheus Holdings, Inc. develops and commercializes diagnostic medical imaging agents in the Pharmaceuticals & Biotechnology industry. As of March 2025, it reported net sales of $373 million and a net profit of $73 million, with a market cap of approximately $5.39 billion.
Overview:
Lantheus Holdings, Inc. is engaged in the development, manufacture, and commercialization of diagnostic medical imaging agents and products within the Pharmaceuticals & Biotechnology industry, categorized as a small-cap company.

Financial Snapshot:
Most recent Net Sales: 373 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: 73 Million (Quarterly Results - Mar 2025)
Market-cap: USD 5,390.96 Million (Small Cap)

Key Metrics:
P/E: 15.00
Dividend Yield: 0.00%
Debt Equity: -0.32
Return on Equity: 31.84%
Price to Book: 4.63

Contact Details:
Address: 331 Treble Cove Rd, NORTH BILLERICA MA: 01862-2849
Tel: 1 978 6718001
Fax: 1 302 6365454
Website: http://www.lantheus.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News